Introduction
Target organ damage (TOD) has been shown to have an adverse prognostic significance that is independent of blood pressure (BP) and traditional risk factors in hypertensive patients. [1] [2] [3] [4] Subclinical signs of TOD, such as left ventricular hypertrophy (LVH), carotid wall thickening and/or plaque build-up, alteration of arterial stiffness, microalbuminuria (MA) and a slight increase in serum creatinine, have been included in the list of hypertensive TOD by the 2007 European Society of Hypertension/European Society of Cardiology guidelines for the management of arterial hypertension. 5 Flow-mediated dilatation (FMD) of the brachial artery is a marker of endothelial function and can be measured during reactive hyperaemia using highresolution ultrasound. 6 FMD occurs mainly as the result of endothelial release of nitric oxide and correlates with coronary endothelial function. 7 Impairment of FMD is also associated with hypertension. [8] [9] [10] Consequently, antihypertensive treatment improves endothelial function. 11, 12 Little is known about the clinical correlation of endothelial function and multiple TOD in essential hypertension. In this study, we evaluated whether FMD could be an indicator for multiple organ damage in essential hypertensive patients.
Materials and methods

Study population
Two hundred and eighty patients with hypertension (162 men, 118 women), ranging from 22 to 83 years of age (mean: 59 ± 10), were recruited from the outpatient clinic of Ruijin Hospital Shanghai, PR China. Exclusion criteria included ischaemic stroke, cerebral haemorrhage, transient ischaemic attack, myocardial infarction, angina, coronary revascularization, heart failure, diabetic nephropathy, renal impairment (serum creatinine M4133, W4124 mmol l À1 ), peripheral artery disease and tumour.
Participants underwent physical examination and blood tests to assess cardiovascular risk factors including age, gender, waist, waist-hip ratio, C-reactive protein, body mass index (BMI), smoking, the history of hypertension, systolic BP (SBP), diastolic BP (DBP), pulse pressure (PP), plasma fasting glucose, serum total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglyceride, serum creatinine, urinary albumin-creatinine ratio (UACR) and intima-media thickness (IMT) of the common carotid. 
Definition of TOD
Assessment of brachial artery endothelial function
Arterial endothelial function of the brachial artery was assessed non-invasively by means of ultrasound examination, as reported earlier. 13 High-resolution echocardiography Doppler ultrasound (HD11EX ultrasound; Philips Medical Systems, Andover, MA, USA) with a broad-band linear array transducer (multiple frequency: 4-12 MHz) was used to measure the flow velocity and diameter of the right brachial arteries. The right brachial artery, proximal to the antecubital fossa, was imaged longitudinally using the linear-array transducer. FMD was assessed by measuring the brachial artery diameter at baseline and during reactive hyperaemia. Reactive hyperaemia was induced by deflating a cuff previously inflated to at least 50 mm Hg above systolic pressure for 5 min in the upper arm. Arterial flow velocity was measured at baseline and during reactive hyperaemia using pulsed-wave Doppler. After 15 min, the endothelium-independent response was assessed by the change in artery diameter at 3 min after a 400 mg dose of sublingual glyceryl trinitrate. All scans were recorded by a computer for analysis. The parameters were measured for three consecutive cardiac cycles with the top of the R wave on the electrocardiogram and the average was taken.
Measurement of arterial stiffness
Pulse wave velocity was measured automatically with a Complior SP (Artech-Medical co., Paris, France) device according to the methods described earlier.
14 Briefly, cf-PWV was calculated from measurements of the pulse transit time between the two recording sites, namely the femoral and common carotid arteries. During preprocessing analysis, the gain of each waveform was adjusted to generate a signal of equal magnitude for the two waveforms.
Statistical analysis
Data are presented as mean±s.d. unless otherwise stated. Within the patient group, Pearson correlation analysis was used to identify possible relationships between FMD and cardiovascular risk factors. A stepwise multiple linear regression analysis was used to identify significant determinants of FMD and TOD. One-way analysis of variance was used to compare FMD among the four groups of patients with different numbers of TOD. Statistical significance was defined as Po0.05. All statistical analyses were performed using SPSS Version 11.5 (SPSS Inc.).
Results
Patient population
Of the 280 patients, 58% were men and 42% were women, with respective mean ages of 59 ± 10 years and 60 ± 8 years; 9.3% had DM, 86% had a family history of hypertension and 32% were smokers; 61 patients had no TOD, 113 had damage in one target organ, 59 had two target organs damaged and 47 had X3 target organs damaged. Patients in the hypertensive population were using oral antihypertensive agents, including angiotensin-converting enzyme inhibitors (n ¼ 81), angiotensin II receptor blockers (n ¼ 69), calcium antagonists (n ¼ 156), b-blockers (n ¼ 54) and diuretics (n ¼ 23). As the study subjects were using antihypertensive medications that may have affected our FMD results, we analysed the drug ratio in different groups and found there were no significant differences of the proportion of antihypertensive medications in different groups according to the report by Wolff et al.
15 (Table 1) . Otherwise, drug administration was suspended at least 24 h before the measurement of FMD.
Correlation of FMD with cardiovascular risk factors
Univariate analysis identified a relationship between FMD and age (r ¼ À0.235, Po0.001), BMI (r ¼ À0.227, Po0.001), waist size (r ¼ À0.244, Po0.001), waisthip ratio (r ¼ À0.200, P ¼ 0.001), high-density lipoprotein cholesterol (r ¼ 0.186, P ¼ 0.002), SBP (r ¼ À0.125, P ¼ 0.036), PP (r ¼ À0.187, P ¼ 0.002) and the course of hypertension (r ¼ À0.202, P ¼ 0.001). However, there was no relationship between FMD and hypersensitive C-reactive protein, DBP, blood-fasting glucose, postprandial glucose, total cholesterol, triglyceride or low-density lipoprotein cholesterol ( Table 2) . (Figure 4) . However, we did not find a correlation between FMD and UACR. A stepwise multiple regression analysis was performed to evaluate the independent determinants of FMD using age, BMI, waist size, waist-hip ratio, smoking, hypertension history, SBP, PP, serum creatinine, UACR, cf-PWV, IMT and LVMI. We found that FMD still correlated with waist (b ¼ À0.283, Po0.01), age (b ¼ À0.231, Po0.05) and IMT (b ¼ À0.197, P ¼ 0.05) ( Table 3) .
Correlation of FMD with TOD
TOD in hypertensive patients with endothelial dysfunction The patients were divided into two groups as follows: FMDX10% and FMDo10%. Prevalence of IM thickening or plaques and artery stiffness in the FMDo10% groups was higher than that in the FMDX10% group (53.15 vs 23.30%, Po0.01; 60.14 vs 45%, Po0.05). In contrast, the prevalence of LVH and MA was not significantly different between the groups ( Figure 5 ).
Number of TOD and the severity of FMD and nitroglycerin Flow-mediated dilatation was significantly reduced as the total number of TOD increased ( Figure 6 ). FMD was lower in the X3 TOD group (Group IV: 6.85±4.70% vs Group II: 10.00±6.15%, Po0.01), the 2 TOD group (Group III: 7.37 ± 5.02% vs Group II, Po0.01) and the 1 TOD group compared with those in the no TOD group (Group II vs Group I: 11.88±7.11%, Po0.05). FMD was higher in the 2 TOD group than in the X3 TOD group, but the difference was not significant (Group III vs Group IV, P ¼ 0.65). There were no differences between the no TOD and the 1 TOD groups in respect of nitroglycerin (Group I: 13.20 ± 7.61% vs Group II: 11.01±6.81%, P40.05). However, nitroglycerin was lower in the 2 TOD group (Group III: 8.57 ± 5.64% vs Group I, Po0.01) and in the X3 TOD group (Group IV: 9.05±6.53% vs Group I, Po0.01) as compared with the no TOD group. Adjusted for age, BMI, waist, waist-hip ratio, SBP, PP and the duration of hypertension, FMD was still lower in the 2 and X3 TOD groups compared with the 1 TOD and no TOD groups. However, there were Flow-mediated dilatation and TOD in hypertensives J-Z Xu et al no differences between all the groups in respect of nitroglycerin.
Discussion
The endothelium is the largest endocrine and paracrine organ in the body. FMD is an appropriate method to assess endothelial function in humans because it is non-invasive and reflects nitric oxide availability. Although the mechanisms of the relationship between hypertension and endothelial dysfunction are unknown, it has been proposed that endothelial dysfunction causes hypertension, which aggravates the impairment of endothelial function. 16 In one of the larger studies, Yan et al. 17 assessed brachial artery FMD in 1578 middle-aged men without known cardiovascular diseases. Univariate analyses showed that impaired brachial artery FMD was correlated to SBP and DBP. In this study, we found an inverse relationship between FMD and SBP, PP and the duration of hypertension. However, no relationship between FMD and DBP was found, which confirmed with other reports. 18 Many studies have investigated the relationship between FMD and cardiovascular risk factors. Benjamin et al. 19 investigated 2883 patients and found that FMD was inversely correlated with age, BP, BMI, lipid-lowering therapy and smoking. In their multivariate analysis, FMD was associated with BMI and female sex. Yeboah et al. 17 assessed 2338 patients and found that FMD was significantly correlated with age, BMI, high-density lipoprotein cholesterol levels, waist-hip ratio, serum cholesterol and the number of cardiovascular risk factors. In this Flow-mediated dilatation and TOD in hypertensives J-Z Xu et al study, we confirmed that the impairment of FMD correlated with age, BMI, waist size, waist-hip ratio and high-density lipoprotein cholesterol. These findings suggested that endothelial dysfunction may be an early stage in the pathogenesis of cardiovascular disease and may be one of its most important risk factors. Many earlier studies reported the relationship between FMD and single TOD. In this study, we found that FMD in hypertensive patients was inversely related with serum creatinine, cf-PWV, carotid IMT and LVMI, as reported earlier. [20] [21] [22] However, we identified no relationship between FMD and UACR. We observed that lower FMD correlated with higher serum creatinine, suggesting that impaired endothelial function may be associated with renal dysfunction in hypertensive patients. Several studies have shown a significant correlation between FMD and carotid IMT, 20, 21 a result that is echoed in this study. Other studies reported different results. 17, 18 A possible reason for this controversy may be the difference in study populations. Those studies that failed to find a relationship between FMD and IMT featured only healthy subjects. LVH is an important target organ in hypertensive cases. In our study, FMD correlated with LVMI, as reported earlier. 22 Malik et al.
23
investigated 469 hypertensive individuals and found that a higher log (UACR þ 0.1) value was associated with lower FMD. However, our study featured 9.3% DM patients, and their UACR was higher than in other hypertensive patients. We believed that this might contribute to our negative result. These findings suggested that FMD was associated with TOD severity. In brief, the severity of TOD was aggravated as FMD was reduced. This study reported waist size, age and IMT as predictors of FMD reduction, independent of other covariates including BMI, SBP, PP and hypertension history. It should be emphasized that alterations in IMT of carotid arteries are a well-recognized marker of TOD of adverse prognostic significance.
2 Our regression model showed that large waist size, old age and IM thickening might predict the presence in hypertensive patients of endothelial dysfunction. In FMDo10% group, the prevalence of IM thickening or plaques was higher than that in the FMDX10% group. These findings suggested that IM thickening might partly predict endothelial dysfunction. No TOD One TOD P < 0.05 P < 0.05
Two TOD ≥3 TOD Figure 6 The number of target organs damaged and the severity of FMD. FMD was lower in the X3 TOD group (Group IV: 6.85±4.70% vs Group II: 10.00±6.15%, Po0.01), the 2 TOD group (Group III: 7.37 ± 5.02% vs Group II, Po0.01) and the 1 TOD group compared with that in the no TOD group (Group II vs Group I: 11.88 ± 7.11%, Po0.05). FMD, flow-mediated dilatation; TOD, target organ damage. This study reported the relationship between the number of TOD and the severity of endothelial dysfunction in hypertensive patients. We found that FMD was inversely associated with the number of TOD at an early stage of TOD in patients with hypertension, and there is significant decrease between no TOD and 1 TOD, 1 TOD and 2 TOD, but at later stages of TOD in patients with hypertension (42 TOD), there were no differences. On the basis of these results, we suggested that reduced FMD might be an indicator of TOD at an early stage.
In conclusion, this study offered the evidence that reduced FMD might be associated with the number of target organs damaged. As the total number of TOD increased, FMD decreased significantly. FMD may be considered an early indicator for evaluating TOD in hypertensive patients. To confirm this hypothesis, we would recommend a follow-up study that involves a larger patient cohort.
